Zamaneh Mikhak - Jul 3, 2024 Form 4 Insider Report for TFF Pharmaceuticals, Inc. (TFFP)

Role: Chief Medical Officer
Signature: /s/ Zamaneh Mikhak
Stock symbol: TFFP
Transactions as of: Jul 3, 2024
Transactions value $: $0
Form type: 4
Date filed: 7/8/2024, 05:42 PM
Previous filing: Apr 22, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TFFP	Common Stock	Award	$0	+10.2K	+7.54%	$0.00	145K	Jul 3, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TFFP	Stock Options (Right to Buy)	Award	$0	+10.2K		$0.00	10.2K	Jul 3, 2024	Common stock	10.2K	$1.82	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock underlying restricted stock units ("RSUs"). Each RSU entitles its holder to receive one share of common stock of the issuer. The RSUs vest and settle in sixteen equal quarterly installments with a one-year cliff.
F2	One-quarter of the options vest and first become exercisable on June 19, 2025 and the remainder of the options vest and first become exercisable in 12 equal quarterly installments commencing on September 19, 2025.